Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peri-operative acetylsalicylic acid for prevention of embolic stroke after endovascular coiling of unruptured brain aneurysms
2022-003315-28Phase 3Active
- Sponsor
- University of Calgary
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in brain aneurysm (IA), cerebral embolism and thromboembolism comparing Acetylsalicylic acid arm with Placebo arm (2 arms). Primary endpoint: Incidence of embolic strokes at Day 5. Started Nov 2022; status: active.
02
Drugs
aspirin
03
Conditions
brain aneurysm (IA)cerebral embolismthromboembolism
Beyond the preview
Go deeper on 2022-003315-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003315-28.